SEARCH

SEARCH BY CITATION

References

  • Alderwick LJ, Seidel M, Sahm H, Besra GS & Eggeling L (2006) Identification of a novel arabinofuranosyl transferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J Biol Chem 281: 1565315661.
  • Andersson GE & Sharp PM (1996) Codon usage in the Mycobacterium tuberculosis complex. Microbiology 142: 915925.
  • Azuma I, Thomas DW, Adam A, Ghuysen JM, Bonaly R, Petit JF & Lederer E (1970) Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta 208: 444451.
  • Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, De Lisle G & Jacobs WR Jr (1994) Inha, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263: 227230.
  • Berger BJ & Knodel MH (2003) Characterisation of methionine adenosyltransferase from Mycobacterium smegmatis and M. tuberculosis. BMC Microbiol 3: 12.
  • Bugg TD & Walsh CT (1992) Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance. Nat Prod Rep 9: 199215.
  • Cirillo JD, Weisbrod TR, Banerjee A, Bloom BR & Jacobs WR Jr (1994) Genetic determination of the meso-diaminopimelate biosynthetic pathway of mycobacteria. J Bacteriol 176: 44244429.
  • Corbett EL, Marston B, Churchyard GJ & De Cock KM (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367: 926937.
  • Dover LG, Cerdeno-Tarraga AM, Pallen MJ, Parkhill J & Besra GS (2004) Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae. FEMS Microbiol Rev 28: 225250.
  • Dye C (2006) Global epidemiology of tuberculosis. Lancet 367: 938940.
  • Gao GF, Gerth UC, Wyer JR, Willcox BE, O'Callaghan CA, Zhang Z, Jones EY, Bell JI & Jakobsen BK (1998) Assembly and crystallization of the complex between the human T cell coreceptor CD8alpha homodimer and HLA-A2. Protein Sci 7: 12451249.
  • Gao LY, Laval F, Lawson EH, Groger RK, Woodruff A, Morisaki JH, Cox JS, Daffe M & Brown EJ (2003) Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol Microbiol 49: 15471563.
  • Glauner B & Schwarz U (1983) The analysis of murein composition with high-pressure-liquid chromatography. The Target of Penicillin (HakenbeckR, HoltjeJ-V & LabischinskiH. eds), pp. 2934. Walter de Gruyter & Co., Berlin, Germany.
  • Goffin C & Ghuysen JM (2002) Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins vs. lack of efficiency of penicillin as therapeutic agent. Microbiol Mol Biol Rev 66: 702738, table of contents.
  • Higgins W, Tardif C, Richaud C, Krivanek MA & Cardin A (1989) Expression of recombinant diaminopimelate epimerase in Escherichia coli. Isolation and inhibition with an irreversible inhibitor. Eur J Biochem 186: 137143.
  • Ikemura T (1985) Codon usage and transfer-RNA content in unicellular and multicellular organisms. Mol Biol Evol 2: 1334.
  • Janczura E, Leyh-Bouille M, Cocito C & Ghuysen JM (1981) Primary structure of the wall peptidoglycan of leprosy-derived corynebacteria. J Bacteriol 145: 775779.
  • Kanekiyo M, Matsuo K, Hamatake M et al. (2005) Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette–Guerin expressing human immunodeficiency virus type 1 Gag. J Virol 79: 87168723.
  • Kilburn JO & Takayama K (1981) Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. Antimicrob Agents Chemother 20: 401404.
  • Ko HJ, Ko SY, Kim YJ, Lee EG, Cho SN & Kang CY (2005) Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B. Infect Immun 73: 56665674.
  • Koo CW & Blanchard JS (1999) Chemical mechanism of Haemophilus influenzae diaminopimelate epimerase. Biochemistry 38: 44164422.
  • Korepanova A, Gao FP, Hua Y, Qin H, Nakamoto RK & Cross TA (2005) Cloning and expression of multiple integral membrane proteins from Mycobacterium tuberculosis in Escherichia coli. Protein Sci 14: 148158.
  • Kremer L, Dover LG, Morehouse C et al. (2001) Galactan biosynthesis in Mycobacterium tuberculosis. Identification of a bifunctional UDP-galactofuranosyltransferase. J Biol Chem 276: 2643026440.
  • Lam LK, Arnold LD, Kalantar TH, Kelland JG, Lane-Bell PM, Palcic MM, Pickard MA & Vederas JC (1988) Analogs of diaminopimelic acid as inhibitors of meso-diaminopimelate dehydrogenase and ll-diaminopimelate epimerase. J Biol Chem 263: 1181411819.
  • Larsen MH, Vilcheze C, Kremer L et al. (2002) Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol Microbiol 46: 453466.
  • LiébecqC, (ed) (1992) Biochemical Nomenclature and Related Documents, Portland Press Ltd, London.
  • Lloyd AJ, Huyton T, Turkenburg J & Roper DI (2004) Refinement of Haemophilus influenzae diaminopimelic acid epimerase (DapF) at 1.75 A resolution suggests a mechanism for stereocontrol during catalysis. Acta Crystallogr D Biol Crystallogr 60: 397400.
  • Mathews DH, Sabina J, Zuker M & Turner DH (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288: 911940.
  • Mikusova K, Yagi T, Stern R, McNeil MR, Besra GS, Crick DC & Brennan PJ (2000) Biosynthesis of the galactan component of the mycobacterial cell wall. J Biol Chem 275: 3389033897.
  • Mills JA, Motichka K, Jucker M et al. (2004) Inactivation of the mycobacterial rhamnosyltransferase, which is needed for the formation of the arabinogalactan-peptidoglycan linker, leads to irreversible loss of viability. J Biol Chem 279: 4354043546.
  • Nakamura Y, Gojobori T & Ikemura T (2000) Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 28: 292.
  • Petit JF, Adam A, Wietzerbin-Falszpan J, Lederer E & Ghuysen JM (1969) Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan. Biochem Biophys Res Commun 35: 478485.
  • Quemard A, Lacave C & Laneelle G (1991) Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob Agents Chemother 35: 10351039.
  • Richaud C, Higgins W, Mengin-Lecreulx D & Stragier P (1987) Molecular cloning, characterization, and chromosomal localization of dapF, the Escherichia coli gene for diaminopimelate epimerase. J Bacteriol 169: 14541459.
  • Scapin G, Reddy SG & Blanchard JS (1996) Three-dimensional structure of meso-diaminopimelic acid dehydrogenase from Corynebacterium glutamicum. Biochemistry 35: 1354013551.
  • Takayama K, David HL, Wang L & Goldman DS (1970) Isolation and characterization of uridine diphosphate-N-glycolylmuramyl-l-alanyl-gamma-d-glutamyl-meso-alpha,alpha′-diaminopimelic acid from Mycobacterium tuberculosis. Biochem Biophys Res Commun 39: 712.
  • Takayama K, Armstrong EL, Kunugi KA & Kilburn JO (1979) Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother 16: 240242.
  • Wheeler PR & Blanchard JS (2005) General metabolism and biochemical pathways of tubercle bacilli. Tuberculosis and the Tubercle Bacillus (ColeST, EisenachKD, McMurrayDN & JacobsWRJr, eds), pp. 309340. ASM Press, Washington, DC.
  • WHO (2003) The World Health Organization Global Tuberculosis Program, World Health Organization. http://www.who.int/gtbl
  • Wietzerbin J, Das BC, Petit JF, Lederer E, Leyh-Bouille M & Ghuysen JM (1974) Occurrence of d-alanyl-(d)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry 13: 34713476.
  • Wiseman JS & Nichols JS (1984) Purification and properties of diaminopimelic acid epimerase from Escherichia coli. J Biol Chem 259: 89078914.
  • Wright A, Bai G, Barrera L et al. (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs – worldwide, 2000–2004. MMWR 55: 301305.